| Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis P Dong, M Karaayvaz, N Jia, M Kaneuchi, J Hamada, H Watari, S Sudo, ... Oncogene 32 (27), 3286-3295, 2013 | 352 | 2013 |
| MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1 P Dong, M Kaneuchi, H Watari, J Hamada, S Sudo, J Ju, N Sakuragi Molecular cancer 10 (1), 99-108, 2011 | 277 | 2011 |
| Tumor-intrinsic PD-L1 signaling in cancer initiation, development and treatment: beyond immune evasion P Dong, Y Xiong, J Yue, SJB Hanley, H Watari Frontiers in oncology 8, 386-394, 2018 | 272 | 2018 |
| Long non-coding RNA NEAT1: a novel target for diagnosis and therapy in human tumors P Dong, Y Xiong, J Yue, SJB Hanley, N Kobayashi, Y Todo, H Watari Frontiers in genetics 9, 471, 2018 | 219 | 2018 |
| MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells Y Konno, P Dong, Y Xiong, F Suzuki, J Lu, M Cai, H Watari, T Mitamura, ... Oncotarget 5 (15), 6049-6062, 2014 | 172 | 2014 |
| The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer P Dong, Y Konno, H Watari, M Hosaka, M Noguchi, N Sakuragi Journal of translational medicine 12 (1), 231-240, 2014 | 132 | 2014 |
| Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas P Dong, K Nabeshima, N Nishimura, T Kawakami, T Hachisuga, ... Cancer letters 243 (1), 120-127, 2006 | 130 | 2006 |
| Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes P Dong, Y Xiong, J Yue, D Xu, K Ihira, Y Konno, N Kobayashi, Y Todo, ... Journal of Experimental & Clinical Cancer Research 38 (1), 295-310, 2019 | 127 | 2019 |
| MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells P Dong, Y Xiong, H Watari, SJB Hanley, Y Konno, K Ihira, T Yamada, ... Journal of Experimental & Clinical Cancer Research 35 (1), 132-141, 2016 | 123 | 2016 |
| B7H3 As a Promoter of metastasis and promising therapeutic target P Dong, Y Xiong, J Yue, SJB Hanley, H Watari Frontiers in Oncology 8, 264-272, 2018 | 119 | 2018 |
| Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells W Huo, G Zhao, J Yin, X Ouyang, Y Wang, C Yang, B Wang, P Dong, ... Journal of Cancer 8 (1), 57-64, 2017 | 104 | 2017 |
| MicroRNA‐106b modulates epithelial–mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines P Dong, M Kaneuchi, H Watari, S Sudo, N Sakuragi Molecular carcinogenesis 53 (5), 349-359, 2014 | 99 | 2014 |
| Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer P Dong, Y Xiong, J Yu, L Chen, T Tao, S Yi, SJB Hanley, J Yue, H Watari, ... Oncogene 37 (39), 5257–5268, 2018 | 91 | 2018 |
| Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway P Dong, Z Xu, N Jia, D Li, Y Feng Molecular cancer 8 (1), 103-110, 2009 | 90 | 2009 |
| Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges P Dong, Y Xiong, J Yue, S JB Hanley, N Kobayashi, Y Todo, H Watari Cancers 11 (2), 234-249, 2019 | 85 | 2019 |
| EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis K Ihira, P Dong, Y Xiong, H Watari, Y Konno, SJB Hanley, M Noguchi, ... Oncotarget 8 (8), 13509-13520, 2017 | 79 | 2017 |
| Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis Q Zhang, P Dong, X Liu, N Sakuragi, SW Guo Scientific reports 7 (1), 6804-6096, 2017 | 78 | 2017 |
| iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling Y Xiong, F Sun, P Dong, H Watari, J Yue, M Yu, C Lan, Y Wang, Z Ma Journal of Experimental & Clinical Cancer Research 36 (1), 48-58, 2017 | 77 | 2017 |
| microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway T Mitamura, H Watari, L Wang, H Kanno, M Miyazaki, M Kitagawa, ... Molecular Cancer 13 (1), 140-151, 2014 | 72 | 2014 |
| Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway P Dong, Y Xiong, Y Konno, K Ihira, N Kobayashi, J Yue, H Watari Journal of Experimental & Clinical Cancer Research 40 (1), 216-232, 2021 | 69 | 2021 |
Mohammad TaheriInstitute of Human Genetics, Jena, Germany在 uni-jena.de 的电子邮件经过验证
